TJ 41

Drug Profile

TJ 41

Alternative Names: Bu-Zhong-Yi-Qi-Tang; Hocheukki-to; Hochu-ekki-to; Hochuekikito

Latest Information Update: 07 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tsumura
  • Developer Nonindustrial source; Tsumura
  • Class Antineoplastics; Nootropics; Phytotherapies
  • Mechanism of Action Immunostimulants; Natural killer cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Male infertility
  • No development reported Cancer; Herpes simplex virus infections

Most Recent Events

  • 19 Sep 2001 Preclinical development for Herpes simplex virus infections in Japan (PO)
  • 19 Sep 2001 A study has been added to the Viral Infections pharmacodynamics section 857392
  • 28 May 2000 Launched for Male infertility in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top